700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02612

Synthetic patientMETA-24 · Day 145 · 35–44 · M · baseline S16Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
30%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S16
  2. Day 24 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 24.

Primary contributors, last 14 days
  • Nutritional resilience-14
  • GI instability+12
  • Toxicity+7
  • Inflammatory activity+6
  • Treatment adherence+3

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    72 min
    worsening · -5.4 vs previous 14 d
    Sleep duration
    Wearable
    6.9 h
    stable · -0.2 vs previous 14 d
    Energy level
    Daily log
    5.1/10
    worsening · -0.7 vs previous 14 d
    Steps
    Wearable
    8,773
    worsening · -420 vs previous 14 d
    GI burden
    Companion
    15.8/100
    worsening · +8.5 vs previous 14 d
    Adherence
    Companion
    85.6 %
    improving · +6.2 vs previous 14 d
    Sleep quality
    Wearable
    55.5/100
    worsening · -4.5 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    131 mg/dL
    worsening · +5.1 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 70 from the failing basin, 50 from restoration.

    Would help
    • No untried action with strong evidence. Compose one from primitives.
    • More protein
      GI -7 next day on high-intake days · n 22
    Would not help
    • BR-03 Behavioural Recommendation
      only 27% improved among 11 similar
    • Keep alcohol low
      GI +6.8 next day on high-intake days · n 16
    • Keep ultra-processed low
      GI +6 next day on high-intake days · n 15
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -7supporter · 95%
    • Alcohol
      +6.8detractor · 95%
    • Ultra-processed food
      +6detractor · 95%
    • Simple carbohydrates
      +2.1no signal · 33%
    • Dietary fat load
      +1.1no signal · 20%
    • Histamine load
      -0.8no signal · 15%
    • Insoluble fibre
      +0.6no signal · 15%
    • Caffeine
      +0.4no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling ↑45
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
    • Butyrate / short-chain fatty acid production ↓25
      • MicrobiomeF. prausnitzii depleted
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 3.9 · butyrate capacity 68/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    59 ms
    Sleep
    7.4 h
    Steps
    8,153
    Resting HR
    58 bpm
    Daily log: GI score 16, nutritional resilience 65, adherence 86.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0209334%S05AD-05no change40
    P-0255234%S07AD-05no change29
    P-0203130%S12AD-05improved47
    P-0228530%S14AD-05no change39
    P-0233137%S14BR-03improved34
    P-0252236%S01BR-03no change40
    P-0243934%S08BR-03no change40
    P-0256434%S15BR-03improved32
    P-0230832%S13BR-03no change27
    P-0232532%S19BR-03no change33
    P-0208729%S01BR-03no change40
    P-0226725%S09BR-03no change45